Axinn represented Tecomet, together with its sponsor Charlesbank, as antitrust counsel in Tecomet's combination with Orchid Orthopedic Solutions, forming a scaled global manufacturing partner serving MedTech and Aerospace & Defense customers. The transaction closed on May 14, 2026.
The Axinn team was led by partners John Harkrider and Craig Minerva and included partner James Hunsberger, counsel Carol Xianxiao Liu and Monica Smith, and associates John Bogert, Quinten Stewart, Kaitlin Rittgers, and Robert Walmsley.
More details can be found here.